Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the hidradenitis suppurativa market grown over the years?
The market size for hidradenitis suppurativa has seen significant enlargement in the past few years. It is projected to increase from $1.16 billion in 2024 to $1.25 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.8%. The surge during the historical phase could be, in part, ascribed to heightened awareness of diagnoses, scarce treatment alternatives, progressive developments in dermatology, escalating disease prevalence, and initiatives advocating for patients.
What Is the forecasted market size and growth rate for the hidradenitis suppurativa market?
Expectations for the growth of the hidradenitis suppurativa market remain robust with predictions seeing it expand to a $1.63 billion market by 2029, registering a compound annual growth rate (CAGR) of 7.0%. The predicted growth during this forecast period can be linked to several factors, including the development of biologic therapies, precision medicine advancements, expansion in clinical trials, global initiatives and financial backing, along with support from healthcare policies. The forecast period also points at key trends like the advent of advanced immunomodulatory therapies, the rise of telemedicine and remote monitoring, focus on patient-centered care, the integration of minimally invasive surgical procedures, and tailored lifestyle recommendations.
Get your hidradenitis suppurativa market report here!
https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report
What are the major factors driving growth in the hidradenitis suppurativa market?
The escalating occurrence of a variety of skin conditions is propelling the growth trajectory of the hidradenitis suppurativa market. The term skin diseases encompasses a broad spectrum of skin complications, which can be a result of bacterial, viral, or fungal infections, allergic reactions, skin malignancies, and parasites. The market’s expansion is largely due to hidradenitis suppurativa (HS), a persistent, severe skin condition that has encouraged the production of new treatment options and services. This is fuelled by increased awareness, precise diagnosis, a widening patient demographic, and advancements in research. For instance, the American Cancer Society, an American non-profit organisation with an aim to eradicate cancer, has predicted that there will be 108,270 cases of skin cancer in January 2024. This reflects a 3.2% rise from the 104,930 cases that were reported in 2023. Thus, the escalating prevalence of skin conditions is a crucial factor for growth in the hidradenitis suppurativa market.
What key areas define the segmentation of the global hidradenitis suppurativa Market?
The hidradenitis suppurativa market covered in this report is segmented –
1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne
2) By Product: Tablet, Intravenous (IV) Injection
3) By Route Of Administration: Oral, Parenteral
4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments
5) By End User: Hospital, Specialty Clinic, Homecare, Other End Users
Subsegments:
1) By Folliculitis: Acute Folliculitis, Chronic Folliculitis
2) By Pimples: Non-Inflammatory Pimples, Inflammatory Pimples
3) By Boils: Single Boil, Recurrent Boils
4) By Deep-Acne: Cysts, Nodules
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12599&type=smp
What are the top market players propelling the growth of the hidradenitis suppurativa industry?
Major companies operating in the hidradenitis suppurativa market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Co Ltd., UCB S.A., Leo Pharma A/S, Almirall S.A., Acelyrin Inc., AnaptysBio Inc., Arcutis Biotherapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Yamo Pharmaceuticals, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Chemocentryx, Priovant Therapeutics, Aristea Therapeutics, Samsung Bioepis, Organon, Union Therapeutics, Revance Therapeutics, Dermavant Sciences, Dermira Inc., MedImmune LLC, Taro Pharmaceutical Industries Ltd., Immunic Inc.
What are the key trends shaping the future of the hidradenitis suppurativa market?
The use of biologics has emerged as a significant trend in the hidradenitis suppurativa market. Major firms in this space are committing resources to research and development, achieving approval for biologic treatment of hidradenitis suppurativa and maintaining market dominance. For instance, in June 2023, the European regulatory agency authorized Switzerland-based Novartis AG to produce Cosentyx for hidradenitis suppurativa. Cosentyx, the first and only entirely human biologic that expressly inhibits interleukin-17A, an integral cytokine related to hidradenitis suppurative disease, is an established therapy, having been investigated clinically for more than 14 years.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12599
What regions are dominating the hidradenitis suppurativa market growth?
North America was the largest region in the hidradenitis suppurativa market in 2024. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Office Supplies (Except Paper) Global Market Report 2024
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024
Building Material and Garden Equipment and Supplies Dealers Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
